Binovi Technologies Corp(BNVIF)
USD --+0.00%
Reward39Moderate
Risk67Medium-High
📊75%Data
Revenue down 81% YoY
BNVIF
+0.0 · +0.00%
USD · PINK
Binovi Technologies Corp | Healthcare
Earnings Deterioration
Market Cap:13306
ℹ️
Reward Rating
39
Moderate
Bottom 5% (model universe)
75% data coverage
ℹ️
Risk Rating
67
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BNVIF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Binovi Technologies Corp?

engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

BNVIF · Verdict

Limited reward · elevated risk

BNVIF stands out on volatility and valuation, but watch the balance sheet signal.

Based on 88% data coverage

BNVIF · Verdict

What’s working & what to watch

Strengths 2

  • Volatility95/100

    Top decile vs peers

  • Valuation67/100

    Above average

Watchouts 4

  • Balance sheet6/100

    Current ratio 0.32

  • Cash flow16/100

    -1166% free-cash-flow margin

  • Growth25/100

    Rev -34.6% CAGR · earnings +50.8%

  • Profitability32/100

    -8790% net margin · -441% ROE

Model-based scoring. For information only — not financial advice.

What is Binovi Technologies Corp?

engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.31K.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (39)

The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap13.31K
P/E RatioN/A
Dividend YieldN/A
52 Week High0.0009
52 Week Low0.0001
Last AnnualFebruary
IPO DateN/A
IncorporatedUSA
Shares Outstanding27M
No. of EmployeesN/A
IndustryHealth Information Services
ExchangePINK
Beta0.11
CurrencyUSD · Reports in CAD
Websitebinovi.com